Washington (AP) -- A Swiss drug company has agreed to stop selling a constipation medicine after it was linked to serious ailments, including heart attack and stroke.
Novartis is withdrawing the drug Zelnorm at the request of the Food and Drug Administration.
Zelnorm is a prescription drug approved for short-term treatment of women with irritable bowel syndrome with constipation. It's also given to people under 65 with chronic constipation.
It was linked to a higher chance of heart attack, stroke and worsening heart chest pain that can become a heart attack.
Doctors who prescribe Zelnorm are advised by the FDA to work with their patients and transition them to other therapies.
Copyright 2007 by the Associated Press. All rights reserved.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.